Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Eco Animal Health GroupFRA:LWA -3.50%71 ROC (Joel Greenblatt) % is 7.70% as of Sep. 2025, which is 71% below its 10-year median of 26.83. GuruFocus rates FRA:LWA with a GF Score™ of 71/100 and a GF Value™ of €1.19. The stock has 5 warning signs investors should review. Among 983 Drug Manufacturers companies, Eco Animal Health Group ranks better than 64.7% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Eco Animal Health Group's annualized ROC (Joel Greenblatt) % for the quarter that ended in Sep. 2025 was 7.70%.
The historical rank and industry rank for Eco Animal Health Group's ROC (Joel Greenblatt) % or its related term are showing as below:
FRA:LWA'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 4.07 Med: 26.83 Max: 63.34
Current: 20.51
During the past 13 years, Eco Animal Health Group's highest ROC (Joel Greenblatt) % was 63.34%. The lowest was 4.07%. And the median was 26.83%.
FRA:LWA's ROC (Joel Greenblatt) % is ranked better than 64.7% of 983
companies
in the Drug Manufacturers industry
Industry Median: 11.46
vs FRA:LWA: 20.51
Eco Animal Health Group's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was -14.40% per year.
Eco Animal Health Group (FRA:LWA) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Eco Animal Health Group ROC (Joel Greenblatt) % Related Terms
Eco Animal Health Group ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Eco Animal Health Group's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eco Animal Health Group ROC (Joel Greenblatt) % Chart
FRA:LWA vs ZTS, UTHR, VTRS: ROC (Joel Greenblatt) % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Eco Animal Health Group's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Eco Animal Health Group ROC (Joel Greenblatt) % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Eco Animal Health Group's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Eco Animal Health Group's ROC (Joel Greenblatt) % falls into.
Eco Animal Health Group ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is two times the semi-annual (Sep. 2025) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 7.70% mean?
Eco Animal Health Group (FRA:LWA) has a ROC (Joel Greenblatt) % of 7.70% as of Sep. 2025. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Eco Animal Health Group and its competitors. This is 71% below median its historical median of 26.83. Over the past decade, Eco Animal Health Group's ROC (Joel Greenblatt) % has ranged from 4.07 to 63.34. According to the industry distribution chart, Eco Animal Health Group ranks #347 out of 983 companies in the Drug Manufacturers industry, placing it in the top 35.3%.
Is Eco Animal Health Group's ROC (Joel Greenblatt) % too high?
Eco Animal Health Group's current ROC (Joel Greenblatt) % of 7.70% is 71% below median its 10-year median of 26.83. Over the past 10 years, this metric has ranged from a low of 4.07 to a high of 63.34. The Drug Manufacturers industry median ROC (Joel Greenblatt) % is 11.46. Eco Animal Health Group's value of 7.70% is 32.8% below this industry median. Based on the distribution chart, Eco Animal Health Group ranks #347 out of 983 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Eco Animal Health Group has a GF Score™ of 71/100, reflecting its overall financial health beyond just this single metric.
How does Eco Animal Health Group's ROC (Joel Greenblatt) % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Eco Animal Health Group ranks #347 out of 983 companies for ROC (Joel Greenblatt) %. This puts Eco Animal Health Group in the upper half of its industry. The industry median ROC (Joel Greenblatt) % is 11.46. Eco Animal Health Group's value of 7.70% is 32.8% below this benchmark. Historically, Eco Animal Health Group's own ROC (Joel Greenblatt) % has ranged from 4.07 to 63.34 over the past decade. While the company's 10-year median is 26.83 vs. the industry median of 11.46, Eco Animal Health Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Drug Manufacturers company?
The median ROC (Joel Greenblatt) % among Drug Manufacturers companies is 11.46, based on 983 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Eco Animal Health Group's current ROC (Joel Greenblatt) % of 7.70% is 32.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Eco Animal Health Group and its competitors. For the Drug Manufacturers industry, the median ROC (Joel Greenblatt) % is 11.46 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Eco Animal Health Group's current ROC (Joel Greenblatt) % is 7.70%, which is 71% below median its own 10-year median of 26.83. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eco Animal Health Group stock overvalued right now?
Eco Animal Health Group (FRA:LWA) has a current ROC (Joel Greenblatt) % of 7.70%. The stock's GF Value™ is €1.19, compared to a current price of €0.97 — trading 18.9% below its estimated fair value. The current ROC (Joel Greenblatt) % is 7.70%, which is 71% below median its 10-year median of 26.83 and 32.8% below the Drug Manufacturers industry median of 11.46. Eco Animal Health Group's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Eco Animal Health Group (FRA:LWA), the current ROC (Joel Greenblatt) % is 7.70% as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eco Animal Health Group (FRA:LWA) Overvalued in 2026?
Based on GuruFocus' analysis, Eco Animal Health Group stock appears to be undervalued.
The current stock price of €0.97 is trading 18.9% below its estimated GF Value™ of €1.19.
Key valuation signals for FRA:LWA:
ROC (Joel Greenblatt) %: 7.70% (71% below median its 10-year median of 26.83)
GF Value™: €1.19 vs. price of €0.97 (18.9% below fair value)
Industry Position: 32.8% below the Drug Manufacturers median (#347 of 983)
No single metric tells the full story. See the FRA:LWA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eco Animal Health Group PLC is an animal health biotech company. It provides quality products for swine and poultry, anti-infectives to treat illness, improve health, and performance. Its products include Aivlosin/Valosin Solutions and Parasite Solutions. The company's segments include Corporate/UK, China and Japan, North America, South and Southeast Asia, Latin America, Europe, and the Rest of the World, with the majority of the revenue deriving from China and Japan.
71GF Score
Get the complete analysis for FRA:LWA
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:LWA has been successfully added to your 
